Therapy Areas: Cardiovascular
LivaNova announces commercial launch of Essenz Perfusion System in China
18 August 2025 - Medical technology company LivaNova PLC (Nasdaq: LIVN) declared on Monday that it has commenced the commercial launch of its Essenz Perfusion System in China, the company's secon...
Viatris' generic iron sucrose injection gains US FDA approval
12 August 2025 - Viatris Inc (Nasdaq:VTRS), a US-based global healthcare company, announced on Monday that the US Food and Drug Administration (FDA) has approved Iron Sucrose Injection, USP, an intrav...
CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio
7 August 2025 - CorMedix Inc (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercialising therapeutic products for life-threatening diseases and conditions, has entered into a ...
US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist
5 August 2025 - Innovent Biologics Inc (HKEX:01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncology, cardiovascular and ...
GEN and Sulfateq report positive Phase 1 data for SUL-238 in Alzheimer's
28 July 2025 -

GEN Pharmaceuticals (GENIL.IS) and Sulfateq B.V. on Monday announced positive results from a Phase 1 trial of SUL-238, a first-in-cla...

Precision BioSciences secures FDA Orphan Drug Designation for PBGENE-DMD to treat Duchenne muscular dystrophy
23 July 2025 - Gene editing company Precision BioSciences Inc (Nasdaq: DTIL) announced on Wednesday that it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for PB...